Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History RGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics RGEN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Repligen Corporation

RGEN
Current price
130.19 USD -3.81 USD (-2.84%)
Last closed 134.00 USD
ISIN US7599161095
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 7 528 535 552 USD
Yield for 12 month +6.19 %
1Y
3Y
5Y
10Y
15Y
RGEN
21.11.2021 - 28.11.2021

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Address: Building 1, Waltham, MA, United States, 02453

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

181.41 USD

P/E Ratio

Dividend Yield

Financials RGEN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures RGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+634 439 000 USD

Last Year

+638 764 000 USD

Current Quarter

+169 172 000 USD

Last Quarter

+167 547 000 USD

Current Year

+274 645 000 USD

Last Year

+284 247 000 USD

Current Quarter

+90 757 000 USD

Last Quarter

+38 841 000 USD
EBITDA 113 392 000 USD
Operating Margin TTM 5.59 %
Price to Earnings
Return On Assets TTM 0.92 %
PEG Ratio 2.59
Return On Equity TTM -1.16 %
Wall Street Target Price 181.41 USD
Revenue TTM 650 428 992 USD
Book Value 35.34 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 10.40 %
Dividend Yield
Gross Profit TTM 332 694 016 USD
Earnings per share -0.42 USD
Diluted Eps TTM -0.42 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 69.30 %
Profit Margin -3.53 %

Stock Valuation RGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 78.74
Enterprise Value Revenue 11.19
Price Sales TTM 11.57
Enterprise Value EBITDA 84.05
Price Book MRQ 3.67

Technical Indicators RGEN

For 52 Weeks

102.97 USD 182.52 USD
50 Day MA 126.92 USD
Shares Short Prior Month 3 391 049
200 Day MA 141.04 USD
Short Ratio 4.73
Shares Short 3 765 995
Short Percent 8.14 %